Skip to main content
Erschienen in: European Journal of Pediatrics 8/2022

20.05.2022 | Original Article

Does the effect of comprehensive respiratory physiotherapy home-program differ in children with cystic fibrosis and non-cystic fibrosis bronchiectasis?

verfasst von: Hulya Nilgun Gurses, Hikmet Ucgun, Melih Zeren, Hilal Denizoglu Kulli, Erkan Cakır

Erschienen in: European Journal of Pediatrics | Ausgabe 8/2022

Einloggen, um Zugang zu erhalten

Abstract

Bronchiectasis is a form of airway damage as a consequence of endobronchial infection and inflammation and may be present in different diseases. The underlying aetiologies include both cystic fibrosis (CF) and a group of non-cystic fibrosis diseases (NCFB) such as immunodeficiency, primary ciliary dyskinesia, or severe pulmonary infection. Although children with CF and non-cystic fibrosis bronchiectasis (NCFB) have many similar clinical features, their responses to exercise may be different. The aim of this study was to compare the efficacy of a comprehensive respiratory physiotherapy (CRP) home-program in children with CF and NCFB. Thirty children with CF and thirty children with NCFB were included in the study. Both groups performed the CRP home-program twice daily for 8 weeks. Pulmonary function, exercise capacity, and respiratory and peripheral muscle strength were assessed at baseline and after 8 weeks of training. Both groups experienced significant improvements in pulmonary function, exercise capacity, and respiratory and peripheral muscle strength (p < 0.001). Maximum expiratory pressure, exercise capacity, and peripheral muscle strength were further improved in NCFB group compared to CF (p < 0.05); however, there was a great variability in the improvements for each variable.
Conclusion: CRP is beneficial both for children with CF and NCFB and adherence to the program was high in both groups.
What is Known:
• Different physiotherapy approaches in the management of non-cystic fibrosis bronchiectasis have been based on the experience gained from the research studies performed in cystic fibrosis.
• Although having similar pathophysiology, these two diseases show variation in some pulmonary and extrapulmonary features.
What is New:
• The respiratory muscle strength and the efficacy of comprehensive respiratory physiotherapy have been compared for the first time in children with cystic fibrosis and non-cystic fibrosis bronchiectasis.
• Comprehensive respiratory physiotherapy provides higher increases in children with non-cystic fibrosis bronchiectasis in exercise capacity and expiratory and peripheral muscle strength; however, there was a great variability in these improvements. Nevertheless, it can be concluded that both groups significantly benefited from the CRP program.
Literatur
10.
Zurück zum Zitat Annoni S, Bellofiore A, Repossini E, Lazzeri M, Nicolini A, Tarsia P (2020) Effectiveness of chest physiotherapy and pulmonary rehabilitation in patients with non-cystic fibrosis bronchiectasis: a narrative review. Monaldi Arch Chest Dis 90(1). https://doi.org/10.4081/monaldi.2020.1107 Annoni S, Bellofiore A, Repossini E, Lazzeri M, Nicolini A, Tarsia P (2020) Effectiveness of chest physiotherapy and pulmonary rehabilitation in patients with non-cystic fibrosis bronchiectasis: a narrative review. Monaldi Arch Chest Dis 90(1). https://​doi.​org/​10.​4081/​monaldi.​2020.​1107
13.
Zurück zum Zitat Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL et al (2019) Standardization of spirometry 2019 update. An official American thoracic society and European respiratory society technical statement. Am J Respiratory Crit Care Med 200(8):e70-e88. https://doi.org/10.1164/rccm.201908-1590ST Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL et al (2019) Standardization of spirometry 2019 update. An official American thoracic society and European respiratory society technical statement. Am J Respiratory Crit Care Med 200(8):e70-e88. https://​doi.​org/​10.​1164/​rccm.​201908-1590ST
15.
Zurück zum Zitat ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:111–7 ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:111–7
19.
Zurück zum Zitat Adams GM (1990) Exercise physiology laboratory manual, 1st edn. Wm C Brown Publishers, Dubuque, IA, USA Adams GM (1990) Exercise physiology laboratory manual, 1st edn. Wm C Brown Publishers, Dubuque, IA, USA
24.
Zurück zum Zitat Venturelli E, Crisafulli E, DeBiase A, Righi D, Berrighi D, Cavicchioli PP et al (2013) Efficacy of temporary positive expiratory pressure (TPEP) in patients with lung diseases and chronic mucus hypersecretion. The UNIKO® project: a multicentre randomized controlled trial. Clin Rehab 27(4):336–46. https://doi.org/10.1177/0269215512458940 Venturelli E, Crisafulli E, DeBiase A, Righi D, Berrighi D, Cavicchioli PP et al (2013) Efficacy of temporary positive expiratory pressure (TPEP) in patients with lung diseases and chronic mucus hypersecretion. The UNIKO® project: a multicentre randomized controlled trial. Clin Rehab 27(4):336–46. https://​doi.​org/​10.​1177/​0269215512458940​
27.
Zurück zum Zitat Radine A, Werner C, Raidt J, Dougherty GW, Kerschke L, Omran H et al (2019) Comparison of nocturnal cough analysis in healthy subjects and in patients with cystic fibrosis and primary ciliary dyskinesia: a prospective observational study. Respiration 97(1):60–69. https://doi.org/10.1159/000493323CrossRefPubMed Radine A, Werner C, Raidt J, Dougherty GW, Kerschke L, Omran H et al (2019) Comparison of nocturnal cough analysis in healthy subjects and in patients with cystic fibrosis and primary ciliary dyskinesia: a prospective observational study. Respiration 97(1):60–69. https://​doi.​org/​10.​1159/​000493323CrossRefPubMed
29.
Zurück zum Zitat Burtin C, Hebestreit H (2015) Rehabilitation in patients with chronic respiratory disease other than chronic obstructive pulmonary disease: exercise and physical activity interventions in cystic fibrosis and non-cystic fibrosis bronchiectasis. Respiration 89(3):181–189. https://doi.org/10.1159/000375170CrossRefPubMed Burtin C, Hebestreit H (2015) Rehabilitation in patients with chronic respiratory disease other than chronic obstructive pulmonary disease: exercise and physical activity interventions in cystic fibrosis and non-cystic fibrosis bronchiectasis. Respiration 89(3):181–189. https://​doi.​org/​10.​1159/​000375170CrossRefPubMed
33.
Zurück zum Zitat Swisher AK, Hebestreit H, Mejia-Downs A, Lowman JD, Gruber W, Nippins M et al (2015) Exercise and habitual physical activity for people with cystic fibrosis: expert consensus, evidence-based guide for advising patients. Cardiopulm Phys Ther J 26(4):85–98CrossRef Swisher AK, Hebestreit H, Mejia-Downs A, Lowman JD, Gruber W, Nippins M et al (2015) Exercise and habitual physical activity for people with cystic fibrosis: expert consensus, evidence-based guide for advising patients. Cardiopulm Phys Ther J 26(4):85–98CrossRef
Metadaten
Titel
Does the effect of comprehensive respiratory physiotherapy home-program differ in children with cystic fibrosis and non-cystic fibrosis bronchiectasis?
verfasst von
Hulya Nilgun Gurses
Hikmet Ucgun
Melih Zeren
Hilal Denizoglu Kulli
Erkan Cakır
Publikationsdatum
20.05.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Pediatrics / Ausgabe 8/2022
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-022-04509-5

Weitere Artikel der Ausgabe 8/2022

European Journal of Pediatrics 8/2022 Zur Ausgabe

Bei Amblyopie früher abkleben als bisher empfohlen?

22.05.2024 Fehlsichtigkeit Nachrichten

Bei Amblyopie ist das frühzeitige Abkleben des kontralateralen Auges in den meisten Fällen wohl effektiver als der Therapiestandard mit zunächst mehrmonatigem Brilletragen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.